Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Remember this

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jul 25, 2022 7:35pm

78 Views

Post# 34849676

RE:RE:RE:RE:RE:Remember this

inquiries@bcsc.bc.ca

doonery wrote: i have called Chris Hopton 5 or 6 times with no return call.Who and what number should i call.Anyone help me on this,.Between family and friends we have 300 thousand shares,shareholder for 12-13 years, and we cant get any conversation anywhere,and only weak press releases.Here is another question,,,Who is buying,who is selling,,if we knew that we would have a better idea if this sbm projects are even real.If it sounds like im fed up ,,i am.Am quite sure i am not alone.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China